Drug – bio-affecting and body treating compositions – Enzyme or coenzyme containing – Hydrolases
Reexamination Certificate
2008-04-01
2008-04-01
Davis, Ruth A (Department: 1651)
Drug, bio-affecting and body treating compositions
Enzyme or coenzyme containing
Hydrolases
C424S094100, C424S094600, C435S183000, C435S200000, C435S201000
Reexamination Certificate
active
10611598
ABSTRACT:
The invention provides methods of treating Pompe's disease using human acid alpha glucosidase. A preferred treatment regime comprises administering greater than 10 mg/kg body weight per week to a patient.
REFERENCES:
patent: 5356804 (1994-10-01), Desnick et al.
patent: 5565362 (1996-10-01), Rosen
patent: 6118045 (2000-09-01), Reuser et al.
patent: WO 93/25567 (1993-12-01), None
patent: WO 97/05571 (1997-02-01), None
Williams et al (Birth Defects: Original Article Series, vol. XVI, No. 1, pp. 415-423 (1980)).
Kikuchi et al., “Clinical and Metabolic Correction of Pompe Disease by Enzyme Therapy in Acid Maltase-deficient Quail”, J. Clinical Invest, vol. 101, No. 4, Feb. 1998, p. 827-833.
Barnes, Alison K. & Wynn, Colin H. “Homology of Lysosomal Enzymes and Related Proteins: Prediction of Posttranslational Modification Site Including Phosphorylation of Mannose and Potential Epitopic and Substrate Binding Sites in the α- and β-Subunits of Hexosaminidases, α-Glucosidase, and Rabbit and Human Isomaltase”Proteins: Structure, Function, and Genetics, 1988, vol. 4, pp. 182-189.
Belen'kii, D. M. et al. “Purification and Properties of Acid α-Glucosidase (γ- Amylase) from Human Liver.” Translated from:Biokhimiya, Sep.-Oct. 1975, 40 (5) pp. 927-933.
Bijvoet, Agnes G. A. et al., “Expression of cDNA-Encoded Human Acid α-Glucosidase in milk of Transgenic Mice,”Biochimica and Biophysica Acta, vol. 1308, 1996, pp. 93-96.
Bresciani, Roberto et al. “Lysosomal acid phophatase is not involved in the dephosphorylation of mannose 6-phosphate containing lysosomal proteins.”Eur. J. of Cell Biol.Jun. 1992, vol. 58, No. 1, pp. 57-61.
de Barsy et al. “Enzyme Replacement in Pompe Disease: an Attempt with Purified Human Acid Alpha Glucosidase”,Birth Defects Original Article Series, 9 (2) pp. 184-190 Mar. 1973.
Hoefsloot, Lies H. et al., “Expression and Routeing of Human Lysosomal α-Glucosidase in Transiently Transfected Mammalian Cells,”Biochemical Journal, 1990, vol. 272, pp. 485-492.
Houdebine, Louis-Marie “Production of pharmaceutical proteins from transgenic animals.”J. of Biotech., 1994, vol. 34, pp. 269-287, Elsevier Publishing.
Kichuchi, et al., “Clinical and Metabolic Correction of Pompe Disease by Enzyme Therapy in Acid Maltase-Deficient Quail”,J. Clin. Invest., 101 (4) pp. 827-833, Feb. 1998.
Minamiura, Noshi et al. “Identity of α-Glucosidase of Human Kidney with Urine F-1 α-Glucosidase.”J. Biochemistry, 1982, vol. 91, pp. 809-816.
Obara, Yoshiaki et al. “Mutual relationship between milk components and lysosome enzymatic activity in abnormal milk,”Japanese Journal of Veterinary Science, 1983, vol. 45, No. 2, pp. 203-208.
Oberkotter, Linda V. et al. “N-acetyl-α-hexosaminidase activity in human breast milk.”International Journal of Biochemistry, 1982, vol. 14, No. 2, pp. 151-154.
Platenburg Gerald J. et al., “Expression of Human Lactoferrin in Milk of Transgenic Mice,”Transgenic Research, 1994, vol. 3, pp. 99-108.
Rochefort, Henri et al., “The Estrogen-Regulated 52K-Cathepsin-D in Breast Cancer: From Biology to Clinical Applications,”Nuclear Medicine and Biology, 1987, vol. 14, No. 4, pp. 377-384.
Van der Ploeg, A. T. et al., “Intravenous Administration of Phosphorylated Acid α-Glucosidase Leads to Uptake of Enzyme in Heart and Skeletal Muscle of Mice,”The Journal of Clinical Investigation, Feb. 1991, vol. 87, No. 2, pp. 513-518.
Van Hove et al., Purification of Recombinant Human Precursor Acid Alpha Glucosidase, Biochemistry and Molecular Biology International, 43 (3) pp. 613-623, Oct. 1997.
Bijvoet, A.G.A., et al., “Recombinant Human Acid α-Glucosidase: High level Production in Mouse Milk, Biochemical Characteristics, Correction of Enzyme Deficiency in GSDII KO Mice,”Hum. Mol. Genet.7(11): 1815024 (1998).
Fuller, M., et al., “Isolation and Characterisation of a Recombinant, Precursor Form of Lysosomal Acid α-Glucosidase,”Eur. J. Biochem., 234: 903-909 (1995).
Hoefsloot, L.H., et al., “Primary Structure and Processing of Lysosomal α-Glucosidase; Homology with the Intestinal Sucrase-Isomaltase Complex,”EMBO, 7(6); 1697-1704 (1988).
Martiniuk, F., et al., “Recombinant Human Acid α-Glucosidase Generated in Bacteria: Antigenic, but Enzymatically Inactive,”DNA and Cell Biol.11(9): 701-706 (1992).
Yang, H.W., et al., “Recombinant Human Acid α-Glucosidase Corrects Acid α-Glucosidase-Deficient Human Fibroblasts, Quail Fibroblasts, and Quail Myoblasts,”Pediatr. Res., 43(3) 374-90 (1998).
Van Hove, J.L.K., et al., “High-Level Production of Recombinant Human Lysosomal Acid α-Glucosidase in Chinese Hamster Ovary Cells Which Targets to Heart Muscle and Corrects Glycogen Accumulation in Fibroblasts from Patient with Pompe Disease,”Proc. Natl. Acad. Sci.93: 65-70 (1996).
Raben, N., et al., “Targeted Disruption of the Acid α-Glucosidase Gene in Mice Causes an Illness with Critical Features of Both Infantile and Adult Human Glycogen Storage Disease Type II,”J. Biol. Chem., 272(30): 19086-19092 (1998).
Byrne, B.J., et al., “Reconstitution of Acid Alpha-Glucosidase Acitiviy in a Mouse Model of Cardioskeletal Myopathy, Pompe's Disease,”Circulation, vol. 98, No. 17 Suppl., Oct. 27, 1998, p. 1737, XP001041662 & 71st Scientific Sessions of the American Heart Association; Dallas, Texas, USA; Nov. 8-11, 1998 ISSN: 0009-7322.
Mutsaers, J.H.G.M., et al., “Determination of the Structure of the Carbohydrate Claims of Acid α-Glucosidase from Human Placenta,”Biochemica et Biophysica Acta911:244-251 (1987).
Yang, H.W., et al., “Recombinant Human α- Glucosidase Corrects Acid α-Glucosidase-Deficient Human Fibroblasts, Quail Fibroblasts, and Quail Myoblast,s”American Journal of Human Genetics, vol. 59: No. 4 Suppl., (1996), p. A209, XP000934192 & 4th Annual Meeting of the American Society of Human Genetics; San Francisco, CA, USA; Oct. 29-Nov. 2, 1996 ISSN: 0002-9297.
Meeker David P.
van Bree Johannes B. M. M.
Venneker Edna H. G.
Davis Ruth A
Genzyme Therapeutic Products Limited Partnership
Hamilton Brook Smith & Reynolds P.C.
LandOfFree
Treatment of Pompe's disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of Pompe's disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of Pompe's disease will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3940349